Company intelligence / Profile preview

Particle Therapeutics

Oxford, England, United Kingdomparticletherapeutics.co.uk ↗

Ownership: Private
Development stage: Other

Overview

Particle Therapeutics is an Oxford-based company specializing in proprietary needle-free particle formulation and delivery technologies for veterinary vaccines. The company previously developed small molecule drugs targeting the glucagon receptor for hypoglycemia, with some programs reaching Phase 3 clinical trials. In late 2020, it transferred its human vaccine intellectual property to Particle Vaccines Canada Limited and now focuses exclusively on animal health applications.

Therapeutic areas: EndocrinologyInfectious Diseases
Modalities: VaccineSmall moleculeDevice
Industry: Veterinary

Partnerships

Particle Vaccines Canada Limited—agreement for human vaccine IP and equity stake

Beyond the preview

Go deeper on Particle Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Particle Therapeutics.

Explore the full profile